Figure 5
From: Real time in vitro studies of doxorubicin release from PHEMA nanoparticles
Effect of monomer [HEMA]. Effect of monomer [HEMA] content on the (a) swelling profile and (b) release profile of the nanoparticles of definite composition [EGDMA] = 1.06 mM, [Bz2O2] = 0.248 mM, % loading = 28%, pH = 7.4, temp. = 37°C.